◀ Back to PXN
PTK2 — PXN
Pathways - manually collected, often from reviews:
-
OpenBEL Selventa BEL large corpus:
Complex of MAPK3-PTK2-PXN
→
GRN
(increases, MAPK3/PTK2/PXN Activity)
Evidence: These effects required the activation of the mitogen-activated protein kinase pathway and paxillin, which upon proepithelin stimulation formed a complex with focal adhesion kinase and active extracellular signal-regulated kinase.
-
OpenBEL Selventa BEL large corpus:
PXN
→
PTK2
(increases, PTK2 Activity, PXN Activity)
Evidence: A downstream target of FAK is paxillin, a phosphoprotein that also can localize to focal adhesion complexes (9).
-
OpenBEL Selventa BEL large corpus:
PXN
→
PTK2
(directlyIncreases, PXN Activity)
Evidence: 7537852;11774284;7615549;15592455;15107421;16254239;16094384;15817476;15572663
-
OpenBEL Selventa BEL large corpus:
PXN
→
PTK2
(directlyIncreases, PXN Activity)
Evidence: 7537852;11774284;10823820;15107421;16254239;15817476;15572663;12408869
-
OpenBEL Selventa BEL large corpus:
Complex of PTK2-PXN
→
PTPN11
(decreases, PTK2/PXN Activity)
Miao et al., Nat Cell Biol 2000*
Evidence: complex
-
BioCarta erk and pi-3 kinase are necessary for collagen binding in corneal epithelia:
ECM/Integrin-alpha/Integrin-betaTalin/Calpain1/actin (active1)/p130cas/FAK/CSK/Paxillin/Vinculin/alp complex (ITGA1-PTK2-BCAR1-ACTN3_ACTN2_ACTN1_ACTN4-ZYX-TLN1-ITGB1-VCL-PXN-CSK-ACTA1-TNS1-CAPN1)
→
ECM/Integrin-alpha/Integrin-betaTalin/Calpain1/actin/p130cas/FAK/CSK/Paxillin/Vinculin/alpha-actinin complex (ACTA1-VCL-ITGB1-ZYX-TNS1-CSK-CAPN1-ITGA1-ACTN3_ACTN2_ACTN1_ACTN4-PTK2-BCAR1-TLN1-PXN)
(actin filament polymerization, collaborate)
-
BioCarta erk and pi-3 kinase are necessary for collagen binding in corneal epithelia:
ECM/Integrin-alpha/Integrin-betaTalin/Calpain1/actin/p130cas/FAK/CSK/Paxillin/Vinculin/alpha-actinin complex (ACTA1-VCL-ITGB1-ZYX-TNS1-CSK-CAPN1-ITGA1-ACTN3_ACTN2_ACTN1_ACTN4-PTK2-BCAR1-TLN1-PXN)
→
PIP2/Gelsolin complex (GSN)
(actin filament polymerization, collaborate)
-
BioCarta ucalpain and friends in cell spread:
FODRIN (SPTAN1)
→
Paxillin/FAK/Talin/SPTAN1/Integrin-alpha/Integrin-beta/ECM/SRC/Ezrin complex (PXN-PTK2-TLN1-SPTAN1-ITGA1-ITGB1-SRC-VIL2)
(modification, collaborate)
-
BioCarta ucalpain and friends in cell spread:
Calpain1 complex (CAPNS1-CAPN1)
→
Paxillin/FAK/Talin/SPTAN1/Integrin-alpha/Integrin-beta/ECM/SRC/Ezrin complex (PXN-PTK2-TLN1-SPTAN1-ITGA1-ITGB1-SRC-VIL2)
(modification, activates)
-
BioCarta ucalpain and friends in cell spread:
Integrin-alpha/Integrin-beta/ECM complex (ITGA1-ITGB1)
→
Paxillin/FAK/Talin/SPTAN1/Integrin-alpha/Integrin-beta/ECM/SRC/Ezrin complex (PXN-PTK2-TLN1-SPTAN1-ITGA1-ITGB1-SRC-VIL2)
(modification, collaborate)
-
BioCarta integrin signaling pathway:
None
→
ECM/Integrin-alpha/Integrin-betaTalin/Calpain1/actin/p130cas/FAK/CSK/Paxillin/Vinculin/alpha-actinin complex (ACTA1-VCL-ITGB1-ZYX-TNS1-CSK-CAPN1-ITGA1-ACTN3_ACTN2_ACTN1_ACTN4-PTK2-BCAR1-TLN1-PXN)
(modification, collaborate)
-
BioCarta integrin signaling pathway:
Zyxin (ZYX)
→
ECM/Integrin-alpha/Integrin-betaTalin/Calpain1/actin/p130cas/FAK/CSK/Paxillin/Vinculin/alpha-actinin complex (ACTA1-VCL-ITGB1-ZYX-TNS1-CSK-CAPN1-ITGA1-ACTN3_ACTN2_ACTN1_ACTN4-PTK2-BCAR1-TLN1-PXN)
(modification, collaborate)
-
BioCarta integrin signaling pathway:
CSK
→
ECM/Integrin-alpha/Integrin-betaTalin/Calpain1/actin/p130cas/FAK/CSK/Paxillin/Vinculin/alpha-actinin complex (ACTA1-VCL-ITGB1-ZYX-TNS1-CSK-CAPN1-ITGA1-ACTN3_ACTN2_ACTN1_ACTN4-PTK2-BCAR1-TLN1-PXN)
(modification, collaborate)
-
BioCarta integrin signaling pathway:
ECM/Integrin-alpha/Integrin-beta/Talin/Paxillin/Vinculin complex (VCL-PXN-ITGA1-ITGB1-TLN1)
→
ECM/Integrin-alpha/Integrin-betaTalin/Calpain1/actin/p130cas/FAK/CSK/Paxillin/Vinculin/alpha-actinin complex (ACTA1-VCL-ITGB1-ZYX-TNS1-CSK-CAPN1-ITGA1-ACTN3_ACTN2_ACTN1_ACTN4-PTK2-BCAR1-TLN1-PXN)
(modification, collaborate)
-
BioCarta integrin signaling pathway:
ECM/Integrin-alpha/Integrin-beta/Talin/Paxillin/Vinculin complex (VCL-PXN-ITGA1-ITGB1-TLN1)
→
FAK (PTK2)
(modification, collaborate)
-
BioCarta integrin signaling pathway:
ECM/Integrin-alpha/Integrin-betaTalin/Calpain1/actin/p130cas/FAK/CSK/Paxillin/Vinculin/alpha-actinin complex (ACTA1-VCL-ITGB1-ZYX-TNS1-CSK-CAPN1-ITGA1-ACTN3_ACTN2_ACTN1_ACTN4-PTK2-BCAR1-TLN1-PXN)
→
Tensin (TNS1)
(modification, collaborate)
-
BioCarta integrin signaling pathway:
ECM/Integrin-alpha/Integrin-betaTalin/Calpain1/actin/p130cas/FAK/CSK/Paxillin/Vinculin/alpha-actinin complex (ACTA1-VCL-ITGB1-ZYX-TNS1-CSK-CAPN1-ITGA1-ACTN3_ACTN2_ACTN1_ACTN4-PTK2-BCAR1-TLN1-PXN)
→
FAK (PTK2)
(modification, collaborate)
-
BioCarta integrin signaling pathway:
ECM/Integrin-alpha/Integrin-betaTalin/Calpain1/actin/p130cas/FAK/CSK/Paxillin/Vinculin/alpha-actinin complex (ACTA1-VCL-ITGB1-ZYX-TNS1-CSK-CAPN1-ITGA1-ACTN3_ACTN2_ACTN1_ACTN4-PTK2-BCAR1-TLN1-PXN)
→
NOLC1
(modification, collaborate)
-
BioCarta integrin signaling pathway:
ECM/Integrin-alpha/Integrin-betaTalin/Calpain1/actin/p130cas/FAK/CSK/Paxillin/Vinculin/alpha-actinin complex (ACTA1-VCL-ITGB1-ZYX-TNS1-CSK-CAPN1-ITGA1-ACTN3_ACTN2_ACTN1_ACTN4-PTK2-BCAR1-TLN1-PXN)
→
Calpain1 (CAPN1)
(modification, collaborate)
-
BioCarta integrin signaling pathway:
ECM/Integrin-alpha/Integrin-betaTalin/Calpain1/actin/p130cas/FAK/CSK/Paxillin/Vinculin/alpha-actinin complex (ACTA1-VCL-ITGB1-ZYX-TNS1-CSK-CAPN1-ITGA1-ACTN3_ACTN2_ACTN1_ACTN4-PTK2-BCAR1-TLN1-PXN)
→
Actin (ACTA1)
(modification, collaborate)
-
BioCarta integrin signaling pathway:
ECM/Integrin-alpha/Integrin-betaTalin/Calpain1/actin/p130cas/FAK/CSK/Paxillin/Vinculin/alpha-actinin complex (ACTA1-VCL-ITGB1-ZYX-TNS1-CSK-CAPN1-ITGA1-ACTN3_ACTN2_ACTN1_ACTN4-PTK2-BCAR1-TLN1-PXN)
→
alpha-actinin (ACTN3/ACTN2/ACTN1/ACTN4)
(modification, collaborate)
-
BioCarta agrin in postsynaptic differentiation:
agrin/Integrin-alpha/Integrin-beta/dystroglycan 1/SRC/FAK/Paxillin/PKL/PIX/PAKs/dystrophin/actin/laminin/cortactin complex (AGRN-ITGA1-ITGB1-DAG1-SRC-PTK2-PXN-GIT2-ARHGEF6_ARHGEF7-PAK3_PAK7_PAK1_PAK2_PAK6_PAK4-DMD-ACTA1-LAMA1_LAMC3_LAMA2_LAMB1_LAMC1_LAMB2_LAMA4_LAMA5_LAMC2_LAMB3_LAMA3-CTTN)
→
Ach R/RAPSYN complex (CHRM1_CHRNA1-RAPSN)
(modification, collaborate)
-
BioCarta agrin in postsynaptic differentiation:
agrin/Integrin-alpha/Integrin-beta/dystroglycan 1/SRC/FAK/Paxillin/PKL/PIX/PAKs/dystrophin/actin/laminin/cortactin complex (AGRN-ITGA1-ITGB1-DAG1-SRC-PTK2-PXN-GIT2-ARHGEF6_ARHGEF7-PAK3_PAK7_PAK1_PAK2_PAK6_PAK4-DMD-ACTA1-LAMA1_LAMC3_LAMA2_LAMB1_LAMC1_LAMB2_LAMA4_LAMA5_LAMC2_LAMB3_LAMA3-CTTN)
→
utrophin (UTRN)
(modification, collaborate)
-
BioCarta agrin in postsynaptic differentiation:
agrin/Integrin-alpha/Integrin-beta/dystroglycan 1/SRC/FAK/Paxillin/PKL/PIX/PAKs/dystrophin/actin/laminin/cortactin complex (AGRN-ITGA1-ITGB1-DAG1-SRC-PTK2-PXN-GIT2-ARHGEF6_ARHGEF7-PAK3_PAK7_PAK1_PAK2_PAK6_PAK4-DMD-ACTA1-LAMA1_LAMC3_LAMA2_LAMB1_LAMC1_LAMB2_LAMA4_LAMA5_LAMC2_LAMB3_LAMA3-CTTN)
→
agrin/Integrin-alpha/Integrin-beta/dystroglycan 1/SRC/FAK/Paxillin/PKL/PIX/PAKs/dystrophin/actin/laminin/cortactin/Ach R/RAPSYN/utrophin complex (AGRN-ITGA1-ITGB1-DAG1-SRC-PTK2-PXN-GIT2-ARHGEF6_ARHGEF7-PAK3_PAK7_PAK1_PAK2_PAK6_PAK4-DMD-ACTA1-LAMA1_LAMC3_LAMA2_LAMB1_LAMC1_LAMB2_LAMA4_LAMA5_LAMC2_LAMB3_LAMA3-CTTN-CHRM1_CHRNA1-RAPSN-UTRN)
(modification, collaborate)
-
BioCarta agrin in postsynaptic differentiation:
Ach R/RAPSYN complex (CHRM1_CHRNA1-RAPSN)
→
agrin/Integrin-alpha/Integrin-beta/dystroglycan 1/SRC/FAK/Paxillin/PKL/PIX/PAKs/dystrophin/actin/laminin/cortactin/Ach R/RAPSYN/utrophin complex (AGRN-ITGA1-ITGB1-DAG1-SRC-PTK2-PXN-GIT2-ARHGEF6_ARHGEF7-PAK3_PAK7_PAK1_PAK2_PAK6_PAK4-DMD-ACTA1-LAMA1_LAMC3_LAMA2_LAMB1_LAMC1_LAMB2_LAMA4_LAMA5_LAMC2_LAMB3_LAMA3-CTTN-CHRM1_CHRNA1-RAPSN-UTRN)
(modification, collaborate)
-
BioCarta agrin in postsynaptic differentiation:
utrophin (UTRN)
→
agrin/Integrin-alpha/Integrin-beta/dystroglycan 1/SRC/FAK/Paxillin/PKL/PIX/PAKs/dystrophin/actin/laminin/cortactin/Ach R/RAPSYN/utrophin complex (AGRN-ITGA1-ITGB1-DAG1-SRC-PTK2-PXN-GIT2-ARHGEF6_ARHGEF7-PAK3_PAK7_PAK1_PAK2_PAK6_PAK4-DMD-ACTA1-LAMA1_LAMC3_LAMA2_LAMB1_LAMC1_LAMB2_LAMA4_LAMA5_LAMC2_LAMB3_LAMA3-CTTN-CHRM1_CHRNA1-RAPSN-UTRN)
(modification, collaborate)
-
BioCarta mcalpain and friends in cell motility:
Calpastatin (CAST)
→
Paxillin/FAK/Talin/Actin/Integrin-alpha/Integrin-beta/ECM complex (PXN-PTK2-TLN1-ACTA1-ITGA1-ITGB1)
(modification, inhibits)
-
BioCarta mcalpain and friends in cell motility:
Actin (ACTA1)
→
Paxillin/FAK/Talin/Actin/Integrin-alpha/Integrin-beta/ECM complex (PXN-PTK2-TLN1-ACTA1-ITGA1-ITGB1)
(modification, collaborate)
-
BioCarta mcalpain and friends in cell motility:
Calpain1 complex (CAPNS1-CAPN1)
→
Paxillin/FAK/Talin/Actin/Integrin-alpha/Integrin-beta/ECM complex (PXN-PTK2-TLN1-ACTA1-ITGA1-ITGB1)
(modification, activates)
-
BioCarta mcalpain and friends in cell motility:
Integrin-alpha/Integrin-beta/ECM complex (ITGA1-ITGB1)
→
Paxillin/FAK/Talin/Actin/Integrin-alpha/Integrin-beta/ECM complex (PXN-PTK2-TLN1-ACTA1-ITGA1-ITGB1)
(modification, collaborate)
-
BioCarta erk and pi-3 kinase are necessary for collagen binding in corneal epithelia:
Rho-Kinase Dia/Profilin complex (PFN1-DIAPH1)
→
ECM/Integrin-alpha/Integrin-betaTalin/Calpain1/actin (active1)/p130cas/FAK/CSK/Paxillin/Vinculin/alp complex (ITGA1-PTK2-BCAR1-ACTN3_ACTN2_ACTN1_ACTN4-ZYX-TLN1-ITGB1-VCL-PXN-CSK-ACTA1-TNS1-CAPN1)
(actin filament polymerization, activates)
-
BioCarta erk and pi-3 kinase are necessary for collagen binding in corneal epithelia:
Rho-Kinase Dia/Profilin complex (PFN1-DIAPH1)
→
ECM/Integrin-alpha/Integrin-betaTalin/Calpain1/actin/p130cas/FAK/CSK/Paxillin/Vinculin/alpha-actinin complex (ACTA1-VCL-ITGB1-ZYX-TNS1-CSK-CAPN1-ITGA1-ACTN3_ACTN2_ACTN1_ACTN4-PTK2-BCAR1-TLN1-PXN)
(actin filament polymerization, activates)
-
BioCarta erk and pi-3 kinase are necessary for collagen binding in corneal epithelia:
ECM/Integrin-alpha/Integrin-betaTalin/Calpain1/actin (active1)/p130cas/FAK/CSK/Paxillin/Vinculin/alp complex (ITGA1-PTK2-BCAR1-ACTN3_ACTN2_ACTN1_ACTN4-ZYX-TLN1-ITGB1-VCL-PXN-CSK-ACTA1-TNS1-CAPN1)
→
ECM/Integrin-alpha/Integrin-betaTalin/Calpain1/actin/p130cas/FAK/CSK/Paxillin/Vinculin/alpha-actinin complex (ACTA1-VCL-ITGB1-ZYX-TNS1-CSK-CAPN1-ITGA1-ACTN3_ACTN2_ACTN1_ACTN4-PTK2-BCAR1-TLN1-PXN)
(actin filament polymerization, collaborate)
-
BioCarta mcalpain and friends in cell motility:
Paxillin/FAK/Talin/MLC(+)/Integrin-alpha/Integrin-beta/ECM complex (PXN-PTK2-TLN1-MLC1-ITGA1-ITGB1)
→
Paxillin/FAK/Talin/MLC/Integrin-alpha/Integrin-beta/ECM complex (PXN-PTK2-TLN1-MLC1-ITGA1-ITGB1)
(modification, collaborate)
-
BioCarta mcalpain and friends in cell motility:
Paxillin/FAK/Talin/MLC/Integrin-alpha/Integrin-beta/ECM complex (PXN-PTK2-TLN1-MLC1-ITGA1-ITGB1)
→
myosin light chain protein kinase (MYLK)
(modification, collaborate)
-
BioCarta agrin in postsynaptic differentiation:
agrin/Integrin-alpha/Integrin-beta/dystroglycan 1/SRC/FAK/Paxillin/PKL/PIX/PAKs/dystrophin/actin/laminin complex (AGRN-ITGA1-ITGB1-DAG1-SRC-PTK2-PXN-GIT2-ARHGEF6_ARHGEF7-PAK3_PAK7_PAK1_PAK2_PAK6_PAK4-DMD-ACTA1-LAMA1_LAMC3_LAMA2_LAMB1_LAMC1_LAMB2_LAMA4_LAMA5_LAMC2_LAMB3_LAMA3)
→
None
(modification, activates)
-
BioCarta agrin in postsynaptic differentiation:
agrin/Integrin-alpha/Integrin-beta/dystroglycan 1/SRC/FAK/Paxillin/PKL/PIX/PAKs/dystrophin/actin/laminin complex (AGRN-ITGA1-ITGB1-DAG1-SRC-PTK2-PXN-GIT2-ARHGEF6_ARHGEF7-PAK3_PAK7_PAK1_PAK2_PAK6_PAK4-DMD-ACTA1-LAMA1_LAMC3_LAMA2_LAMB1_LAMC1_LAMB2_LAMA4_LAMA5_LAMC2_LAMB3_LAMA3)
→
None
(modification, activates)
-
BioCarta agrin in postsynaptic differentiation:
agrin/Integrin-alpha/Integrin-beta/dystroglycan 1/SRC/FAK/Paxillin/PKL/PIX/PAKs/dystrophin/actin/laminin/cortactin complex (AGRN-ITGA1-ITGB1-DAG1-SRC-PTK2-PXN-GIT2-ARHGEF6_ARHGEF7-PAK3_PAK7_PAK1_PAK2_PAK6_PAK4-DMD-ACTA1-LAMA1_LAMC3_LAMA2_LAMB1_LAMC1_LAMB2_LAMA4_LAMA5_LAMC2_LAMB3_LAMA3-CTTN)
→
cortactin (CTTN)
(modification, collaborate)
-
BioCarta agrin in postsynaptic differentiation:
agrin/Integrin-alpha/Integrin-beta/dystroglycan 1/SRC/FAK/Paxillin/PKL/PIX/PAKs/dystrophin/actin/laminin/cortactin complex (AGRN-ITGA1-ITGB1-DAG1-SRC-PTK2-PXN-GIT2-ARHGEF6_ARHGEF7-PAK3_PAK7_PAK1_PAK2_PAK6_PAK4-DMD-ACTA1-LAMA1_LAMC3_LAMA2_LAMB1_LAMC1_LAMB2_LAMA4_LAMA5_LAMC2_LAMB3_LAMA3-CTTN)
→
agrin/Integrin-alpha/Integrin-beta/dystroglycan 1/SRC/FAK/Paxillin/PKL/PIX/PAKs/dystrophin/actin/laminin complex (AGRN-ITGA1-ITGB1-DAG1-SRC-PTK2-PXN-GIT2-ARHGEF6_ARHGEF7-PAK3_PAK7_PAK1_PAK2_PAK6_PAK4-DMD-ACTA1-LAMA1_LAMC3_LAMA2_LAMB1_LAMC1_LAMB2_LAMA4_LAMA5_LAMC2_LAMB3_LAMA3)
(modification, collaborate)
-
BioCarta agrin in postsynaptic differentiation:
cortactin (CTTN)
→
agrin/Integrin-alpha/Integrin-beta/dystroglycan 1/SRC/FAK/Paxillin/PKL/PIX/PAKs/dystrophin/actin/laminin complex (AGRN-ITGA1-ITGB1-DAG1-SRC-PTK2-PXN-GIT2-ARHGEF6_ARHGEF7-PAK3_PAK7_PAK1_PAK2_PAK6_PAK4-DMD-ACTA1-LAMA1_LAMC3_LAMA2_LAMB1_LAMC1_LAMB2_LAMA4_LAMA5_LAMC2_LAMB3_LAMA3)
(modification, collaborate)
-
BioCarta mcalpain and friends in cell motility:
Calpastatin (CAST)
→
Paxillin/FAK/Talin/Actin/Integrin-alpha/Integrin-beta/ECM complex (PXN-PTK2-TLN1-ACTA1-ITGA1-ITGB1)
(modification, inhibits)
-
BioCarta mcalpain and friends in cell motility:
Actin (ACTA1)
→
Paxillin/FAK/Talin/Actin/Integrin-alpha/Integrin-beta/ECM complex (PXN-PTK2-TLN1-ACTA1-ITGA1-ITGB1)
(modification, collaborate)
-
BioCarta mcalpain and friends in cell motility:
Ezrin (VIL2)
→
Paxillin/FAK/Talin/Actin/Integrin-alpha/Integrin-beta/ECM complex (PXN-PTK2-TLN1-ACTA1-ITGA1-ITGB1)
(modification, activates)
-
BioCarta mcalpain and friends in cell motility:
Integrin-alpha/Integrin-beta/ECM complex (ITGA1-ITGB1)
→
Paxillin/FAK/Talin/Actin/Integrin-alpha/Integrin-beta/ECM complex (PXN-PTK2-TLN1-ACTA1-ITGA1-ITGB1)
(modification, collaborate)
-
BioCarta mcalpain and friends in cell motility:
MLC (MLC1)
→
Paxillin/FAK/Talin/MLC(+)/Integrin-alpha/Integrin-beta/ECM complex (PXN-PTK2-TLN1-MLC1-ITGA1-ITGB1)
(modification, collaborate)
-
BioCarta mcalpain and friends in cell motility:
Integrin-alpha/Integrin-beta/ECM complex (ITGA1-ITGB1)
→
Paxillin/FAK/Talin/MLC(+)/Integrin-alpha/Integrin-beta/ECM complex (PXN-PTK2-TLN1-MLC1-ITGA1-ITGB1)
(modification, collaborate)
-
BioCarta mcalpain and friends in cell motility:
Paxillin/FAK/Talin/MLC(+)/Integrin-alpha/Integrin-beta/ECM complex (PXN-PTK2-TLN1-MLC1-ITGA1-ITGB1)
→
Calpain2 complex (CAPNS1-CAPN2)
(modification, collaborate)
-
BioCarta mcalpain and friends in cell motility:
Paxillin/FAK/Talin/MLC(+)/Integrin-alpha/Integrin-beta/ECM complex (PXN-PTK2-TLN1-MLC1-ITGA1-ITGB1)
→
PKA complex (PRKACB-PRKACG-PRKAR1A-PRKAR1B-PRKAR2A-PRKAR2B)
(modification, collaborate)
-
BioCarta mcalpain and friends in cell motility:
Paxillin/FAK/Talin/MLC(+)/Integrin-alpha/Integrin-beta/ECM complex (PXN-PTK2-TLN1-MLC1-ITGA1-ITGB1)
→
Calpastatin (CAST)
(modification, collaborate)
-
BioCarta agrin in postsynaptic differentiation:
agrin/Integrin-alpha/Integrin-beta/dystroglycan 1/SRC/FAK/Paxillin/PKL/PIX/PAKs/dystrophin/actin complex (AGRN-ITGA1-ITGB1-DAG1-SRC-PTK2-PXN-GIT2-ARHGEF6_ARHGEF7-PAK3_PAK7_PAK1_PAK2_PAK6_PAK4-DMD-ACTA1)
→
Laminin (LAMA1/LAMC3/LAMA2/LAMB1/LAMC1/LAMB2/LAMA4/LAMA5/LAMC2/LAMB3/LAMA3)
(modification, collaborate)
-
BioCarta agrin in postsynaptic differentiation:
agrin/Integrin-alpha/Integrin-beta/dystroglycan 1/SRC/FAK/Paxillin/PKL/PIX/PAKs/dystrophin/actin complex (AGRN-ITGA1-ITGB1-DAG1-SRC-PTK2-PXN-GIT2-ARHGEF6_ARHGEF7-PAK3_PAK7_PAK1_PAK2_PAK6_PAK4-DMD-ACTA1)
→
agrin/Integrin-alpha/Integrin-beta/dystroglycan 1/SRC/FAK/Paxillin/PKL/PIX/PAKs/dystrophin/actin/laminin complex (AGRN-ITGA1-ITGB1-DAG1-SRC-PTK2-PXN-GIT2-ARHGEF6_ARHGEF7-PAK3_PAK7_PAK1_PAK2_PAK6_PAK4-DMD-ACTA1-LAMA1_LAMC3_LAMA2_LAMB1_LAMC1_LAMB2_LAMA4_LAMA5_LAMC2_LAMB3_LAMA3)
(modification, collaborate)
-
BioCarta agrin in postsynaptic differentiation:
Laminin (LAMA1/LAMC3/LAMA2/LAMB1/LAMC1/LAMB2/LAMA4/LAMA5/LAMC2/LAMB3/LAMA3)
→
agrin/Integrin-alpha/Integrin-beta/dystroglycan 1/SRC/FAK/Paxillin/PKL/PIX/PAKs/dystrophin/actin/laminin complex (AGRN-ITGA1-ITGB1-DAG1-SRC-PTK2-PXN-GIT2-ARHGEF6_ARHGEF7-PAK3_PAK7_PAK1_PAK2_PAK6_PAK4-DMD-ACTA1-LAMA1_LAMC3_LAMA2_LAMB1_LAMC1_LAMB2_LAMA4_LAMA5_LAMC2_LAMB3_LAMA3)
(modification, collaborate)
-
BioCarta integrin signaling pathway:
ECM/Integrin-alpha/Integrin-betaTalin/Calpain1/actin (active1)/p130cas/FAK/CSK/Paxillin/Vinculin/alp complex (ITGA1-PTK2-BCAR1-ACTN3_ACTN2_ACTN1_ACTN4-ZYX-TLN1-ITGB1-VCL-PXN-CSK-ACTA1-TNS1-CAPN1)
→
ECM/Integrin-alpha/Integrin-betaTalin/Calpain1/actin/p130cas/FAK/CSK/Paxillin/Vinculin/alpha-actinin complex (ACTA1-VCL-ITGB1-ZYX-TNS1-CSK-CAPN1-ITGA1-ACTN3_ACTN2_ACTN1_ACTN4-PTK2-BCAR1-TLN1-PXN)
(actin filament polymerization, collaborate)
-
KEGG Chemokine signaling pathway:
PTK2
→
PXN
(protein-protein, activation)
-
NCI Pathway Database LPA receptor mediated events:
FAK1 (PTK2)
→
Paxillin (PXN)
(modification, collaborate)
Xu et al., J Biol Chem 2004, Lai et al., Mol Cell Biol 2005
Evidence: assay, physical interaction
-
NCI Pathway Database Angiopoietin receptor Tie2-mediated signaling:
Paxillin (PXN)
→
FAK (PTK2)
(focal adhesion formation, collaborate)
Kim et al., Circ Res 2000*, Lee et al., Mol Cancer Res 2006
Evidence: assay
-
NCI Pathway Database CXCR4-mediated signaling events:
FAK/p130 Cas/Paxillin complex (PTK2-BCAR1-PXN)
→
FAK (PTK2)
(modification, collaborate)
Wang et al., Blood 2000, Zhang et al., Blood 2001, Okabe et al., J Hematother Stem Cell Res 2002, Le et al., J Immunol 2005
Evidence: mutant phenotype, assay, physical interaction
-
NCI Pathway Database CXCR4-mediated signaling events:
FAK/p130 Cas/Paxillin complex (PTK2-BCAR1-PXN)
→
p130 Cas (BCAR1)
(modification, collaborate)
Wang et al., Blood 2000, Zhang et al., Blood 2001, Okabe et al., J Hematother Stem Cell Res 2002, Le et al., J Immunol 2005
Evidence: mutant phenotype, assay, physical interaction
-
NCI Pathway Database CXCR4-mediated signaling events:
FAK/p130 Cas/Paxillin complex (PTK2-BCAR1-PXN)
→
Paxillin (PXN)
(modification, collaborate)
Wang et al., Blood 2000, Zhang et al., Blood 2001, Okabe et al., J Hematother Stem Cell Res 2002, Le et al., J Immunol 2005
Evidence: mutant phenotype, assay, physical interaction
-
NCI Pathway Database CXCR4-mediated signaling events:
FAK (PTK2)
→
Paxillin (PXN)
(modification, collaborate)
Wang et al., Blood 2000, Zhang et al., Blood 2001, Okabe et al., J Hematother Stem Cell Res 2002, Le et al., J Immunol 2005
Evidence: mutant phenotype, assay, physical interaction
-
NCI Pathway Database CXCR4-mediated signaling events:
alpha-beta1 Integrin (ITGA8/ITGB1/ITGA10/ITGB1/ITGA6/ITGB1/ITGA1/ITGB1/ITGA3/ITGB1/ITGA2/ITGB1/ITGAV/ITGB1/ITGA11/ITGB1/ITGA4/ITGB1/ITGA7/ITGB1/ITGA5/ITGB1/ITGA9/ITGB1)
→
FAK/p130 Cas/Paxillin complex (PTK2-BCAR1-PXN)
(cell adhesion, collaborate)
Okabe et al., J Hematother Stem Cell Res 2002, Glodek et al., Leukemia 2007
Evidence: mutant phenotype, assay
-
NCI Pathway Database IGF1 pathway:
Crk/p130 Cas/Paxillin/FAK1 complex (CRK-BCAR1-PXN-PTK2)
→
FAK (PTK2)
(modification, collaborate)
Casamassima et al., J Biol Chem 1998
Evidence: assay, physical interaction
-
NCI Pathway Database IGF1 pathway:
Crk/p130 Cas/Paxillin/FAK1 complex (CRK-BCAR1-PXN-PTK2)
→
Crk/p130 Cas/Paxillin complex (CRK-BCAR1-PXN)
(modification, collaborate)
Casamassima et al., J Biol Chem 1998
Evidence: assay, physical interaction
-
NCI Pathway Database IGF1 pathway:
FAK (PTK2)
→
Crk/p130 Cas/Paxillin complex (CRK-BCAR1-PXN)
(modification, collaborate)
Casamassima et al., J Biol Chem 1998
Evidence: assay, physical interaction
-
NCI Pathway Database Signaling events mediated by VEGFR1 and VEGFR2:
FAK/Paxillin complex (PTK2-PXN)
→
Paxillin (PXN)
(modification, collaborate)
Le Boeuf et al., J Biol Chem 2004, Le Boeuf et al., Mol Biol Cell 2006, Abedi et al., J Biol Chem 1997
Evidence: assay, physical interaction
-
NCI Pathway Database Signaling events mediated by VEGFR1 and VEGFR2:
FAK/Paxillin complex (PTK2-PXN)
→
FAK (PTK2)
(modification, collaborate)
Le Boeuf et al., J Biol Chem 2004, Le Boeuf et al., Mol Biol Cell 2006, Abedi et al., J Biol Chem 1997
Evidence: assay, physical interaction
-
NCI Pathway Database Signaling events mediated by VEGFR1 and VEGFR2:
Paxillin (PXN)
→
FAK (PTK2)
(modification, collaborate)
Le Boeuf et al., J Biol Chem 2004, Le Boeuf et al., Mol Biol Cell 2006, Abedi et al., J Biol Chem 1997
Evidence: assay, physical interaction
-
NCI Pathway Database Alpha4 beta1 integrin signaling events:
alpha4/beta1 Integrin/VCAM1/Paxillin complex (VCAM1-PXN-ITGA4-ITGB1)
→
FAK (PTK2)
(modification, activates)
Rose et al., J Immunol 2003, Nojima et al., Cell Immunol 1995*, Manie et al., Blood 1996
Evidence: mutant phenotype
-
NCI Pathway Database Signaling events mediated by focal adhesion kinase:
FAK/Src-Yes-Fyn/Paxillin complex (PTK2-YES1_SRC_FYN-PXN)
→
PAK1/betaPIX/PKL/NCK1-2 complex (PAK1-ARHGEF7-GIT2-NCK2_NCK1)
(modification, collaborate)
Turner et al., J Cell Biol 1999, Brown et al., Mol Biol Cell 2002, Brown et al., Mol Biol Cell 2005, Schober et al., J Cell Biol 2007, Yu et al., Mol Biol Cell 2009
Evidence: physical interaction
-
NCI Pathway Database Signaling events mediated by focal adhesion kinase:
FAK/Src-Yes-Fyn/Paxillin complex (PTK2-YES1_SRC_FYN-PXN)
→
FAK/Src-Yes-Fyn/Paxillin/PAK1/betaPIX/PKL/NCK1-2 complex (PAK1-ARHGEF7-GIT2-NCK2_NCK1-PTK2-YES1_SRC_FYN-PXN)
(modification, collaborate)
Turner et al., J Cell Biol 1999, Brown et al., Mol Biol Cell 2002, Brown et al., Mol Biol Cell 2005, Schober et al., J Cell Biol 2007, Yu et al., Mol Biol Cell 2009
Evidence: physical interaction
-
NCI Pathway Database Signaling events mediated by focal adhesion kinase:
PAK1/betaPIX/PKL/NCK1-2 complex (PAK1-ARHGEF7-GIT2-NCK2_NCK1)
→
FAK/Src-Yes-Fyn/Paxillin/PAK1/betaPIX/PKL/NCK1-2 complex (PAK1-ARHGEF7-GIT2-NCK2_NCK1-PTK2-YES1_SRC_FYN-PXN)
(modification, collaborate)
Turner et al., J Cell Biol 1999, Brown et al., Mol Biol Cell 2002, Brown et al., Mol Biol Cell 2005, Schober et al., J Cell Biol 2007, Yu et al., Mol Biol Cell 2009
Evidence: physical interaction
-
NCI Pathway Database Integrins in angiogenesis:
FAK/Paxillin complex (PTK2-PXN)
→
Paxillin (PXN)
(modification, collaborate)
Le Boeuf et al., Mol Biol Cell 2006, Abedi et al., J Biol Chem 1997
Evidence: assay, physical interaction
-
NCI Pathway Database Integrins in angiogenesis:
FAK/Paxillin complex (PTK2-PXN)
→
FAK (PTK2)
(modification, collaborate)
Le Boeuf et al., Mol Biol Cell 2006, Abedi et al., J Biol Chem 1997
Evidence: assay, physical interaction
-
NCI Pathway Database Integrins in angiogenesis:
Paxillin (PXN)
→
FAK (PTK2)
(modification, collaborate)
Le Boeuf et al., Mol Biol Cell 2006, Abedi et al., J Biol Chem 1997
Evidence: assay, physical interaction
-
NCI Pathway Database LPA receptor mediated events:
Paxillin (PXN)
→
FAK (PTK2)
(cell migration, collaborate)
Park et al., Cell Signal 2006*
Evidence: mutant phenotype, assay
-
NCI Pathway Database CXCR4-mediated signaling events:
None
→
FAK/p130 Cas/Paxillin complex (PTK2-BCAR1-PXN)
(modification, collaborate)
Glodek et al., Leukemia 2007, Chen et al., Blood 2008
Evidence: mutant phenotype, assay
-
NCI Pathway Database CXCR4-mediated signaling events:
RAP1B/GDP complex (RAP1B)
→
FAK/p130 Cas/Paxillin complex (PTK2-BCAR1-PXN)
(modification, collaborate)
Glodek et al., Leukemia 2007, Chen et al., Blood 2008
Evidence: mutant phenotype, assay
-
NCI Pathway Database Signaling events mediated by focal adhesion kinase:
FAK/Src-Yes-Fyn/Paxillin complex (PTK2-YES1_SRC_FYN-PXN)
→
FAK/Src-Yes-Fyn complex (PTK2-YES1_SRC_FYN)
(modification, collaborate)
Turner et al., J Cell Biol 1999, Schaller et al., Mol Biol Cell 1999, Igishi et al., J Biol Chem 1999, Thomas et al., J Biol Chem 1999, Hayashi et al., Nat Struct Biol 2002, Zaidel-Bar et al., J Cell Sci 2007, Pasapera et al., J Cell Biol 2010, Schaller et al., Mol Cell Biol 1995, Hildebrand et al., Mol Biol Cell 1995, Bellis et al., J Biol Chem 1995, Brown et al., J Cell Biol 1996
Evidence: assay, physical interaction
-
NCI Pathway Database Signaling events mediated by focal adhesion kinase:
FAK/Src-Yes-Fyn/Paxillin complex (PTK2-YES1_SRC_FYN-PXN)
→
Paxillin (PXN)
(modification, collaborate)
Turner et al., J Cell Biol 1999, Schaller et al., Mol Biol Cell 1999, Igishi et al., J Biol Chem 1999, Thomas et al., J Biol Chem 1999, Hayashi et al., Nat Struct Biol 2002, Zaidel-Bar et al., J Cell Sci 2007, Pasapera et al., J Cell Biol 2010, Schaller et al., Mol Cell Biol 1995, Hildebrand et al., Mol Biol Cell 1995, Bellis et al., J Biol Chem 1995, Brown et al., J Cell Biol 1996
Evidence: assay, physical interaction
-
NCI Pathway Database Signaling events mediated by focal adhesion kinase:
FAK/Src-Yes-Fyn complex (PTK2-YES1_SRC_FYN)
→
Paxillin (PXN)
(modification, collaborate)
Turner et al., J Cell Biol 1999, Schaller et al., Mol Biol Cell 1999, Igishi et al., J Biol Chem 1999, Thomas et al., J Biol Chem 1999, Hayashi et al., Nat Struct Biol 2002, Zaidel-Bar et al., J Cell Sci 2007, Pasapera et al., J Cell Biol 2010, Schaller et al., Mol Cell Biol 1995, Hildebrand et al., Mol Biol Cell 1995, Bellis et al., J Biol Chem 1995, Brown et al., J Cell Biol 1996
Evidence: assay, physical interaction
-
NCI Pathway Database Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met):
Paxillin (PXN)
→
FAK (PTK2)
(modification, activates)
Ishibe et al., Mol Cell 2003, Wei et al., J Biomed Sci 2009*
Evidence: mutant phenotype
-
Reactome Reaction:
PTK2
→
PXN
(indirect_complex)
Schaller et al., Biochem J 2001, Abedi et al., J Biol Chem 1997
-
Reactome Reaction:
PTK2
→
PXN
(reaction)
Schaller et al., Biochem J 2001, Abedi et al., J Biol Chem 1997
-
WikiPathways Focal Adhesion:
PTK2
→
PXN
(activation)
-
WikiPathways Integrin-mediated Cell Adhesion:
PXN
→
PTK2
(unknown)
-
WikiPathways Chemokine signaling pathway:
PTK2
→
PXN
(activation)
Protein-Protein interactions - manually collected from original source literature:
Studies that report less than 10 interactions are marked with *
-
IRef Bind Interaction:
PXN
—
PTK2
Carragher et al., J Cell Biol 1999*
-
IRef Bind_translation Interaction:
PXN
—
PTK2
(coimmunoprecipitation)
Geng et al., Biochim Biophys Acta 2000
-
IRef Bind_translation Interaction:
PXN
—
PTK2
(unspecified method)
Carragher et al., J Cell Biol 1999*
-
IRef Biogrid Interaction:
PXN
—
PTK2
(direct interaction, pull down)
Liu et al., J Biol Chem 2002*
-
IRef Biogrid Interaction:
PXN
—
PTK2
(direct interaction, pull down)
Mazaki et al., J Biol Chem 1997*
-
IRef Biogrid Interaction:
PXN
—
PTK2
(physical association, affinity chromatography technology)
Zheng et al., J Biol Chem 1998*
-
IRef Biogrid Interaction:
PXN
—
PTK2
(direct interaction, pull down)
Brown et al., J Cell Biol 1996
-
IRef Biogrid Interaction:
PXN
—
PTK2
(physical association, affinity chromatography technology)
Fujita et al., J Biol Chem 1998*
-
IRef Biogrid Interaction:
PXN
—
PTK2
(physical association, affinity chromatography technology)
Zhang et al., J Biol Chem 1999*
-
IRef Biogrid Interaction:
PXN
—
PTK2
(physical association, affinity chromatography technology)
Wang et al., Blood 2000
-
IRef Biogrid Interaction:
PXN
—
PTK2
(physical association, affinity chromatography technology)
Ivankovic-Dikic et al., Nat Cell Biol 2000*
-
IRef Biogrid Interaction:
PXN
—
PTK2
(physical association, affinity chromatography technology)
Kovacic-Milivojević et al., Mol Biol Cell 2001*
-
IRef Biogrid Interaction:
PXN
—
PTK2
(direct interaction, pull down)
Matsuya et al., J Biol Chem 1998*
-
IRef Biogrid Interaction:
PXN
—
PTK2
(direct interaction, pull down)
Turner et al., J Cell Biol 1999
-
IRef Biogrid Interaction:
PXN
—
PTK2
(physical association, affinity chromatography technology)
Liu et al., J Biol Chem 2002*
-
MIPS CORUM PXN-ITGB5-PTK2 complex:
PXN-ITGB5-PTK2 complex complex (ITGB5-PTK2-PXN)
Even-Ram et al., J Biol Chem 2001*
-
MIPS CORUM Polycystin-1 multiprotein complex (ACTN1, CDH1, SRC, JUP, VCL, CTNNB1, PXN, BCAR1, PKD1, PTK2, TLN1):
Polycystin-1 multiprotein complex (ACTN1, CDH1, SRC, JUP, VCL, CTNNB1, PXN, BCAR1, PKD1, PTK2, TLN1) complex (ACTN1-BCAR1-CDH1-CTNNB1-JUP-PKD1-PTK2-PXN-SRC-TLN1-VCL)
Geng et al., Biochim Biophys Acta 2000
-
IRef Corum Interaction:
Complex of 12 proteins
(association, cosedimentation through density gradient)
Geng et al., Biochim Biophys Acta 2000
-
IRef Corum Interaction:
Complex of PXN-ITGB5-PTK2
(association, coimmunoprecipitation)
Even-Ram et al., J Biol Chem 2001*
-
IRef Hprd Interaction:
PTK2
—
PXN
(in vivo)
Lyons et al., J Biol Chem 2001*, Bellis et al., Biochem J 1997*, Brown et al., Mol Biol Cell 1998*
-
IRef Hprd Interaction:
PTK2
—
PXN
(in vitro)
Lyons et al., J Biol Chem 2001*, Bellis et al., Biochem J 1997*, Brown et al., Mol Biol Cell 1998*
-
IRef Hprd Interaction:
Complex of PXN-PTPN1-PTK2-PTK2-PXN-PTPN1-PTK2-PTPN1-PXN
(in vivo)
Liu et al., Mol Cell Biol 1998*
-
IRef Hprd Interaction:
Complex of PXN-BCL2-PTK2-PXN-PTK2-BCL2-PTK2-PXN-BCL2
(in vivo)
Sorenson et al., Dev Dyn 1999*
-
IRef Hprd Interaction:
Complex of PXN-PXN-ITGB5-ITGB5-PXN-PTK2-ITGB5-PTK2-PTK2
(in vivo)
Even-Ram et al., J Biol Chem 2001*
-
IRef Intact Interaction:
PTK2
—
PXN
(physical association, anti bait coimmunoprecipitation)
Scott et al., Cancer Cell 2011*
-
IRef Intact Interaction:
PTK2
—
PXN
(colocalization, confocal microscopy)
Xu et al., Molecular cancer 2010*
-
IRef Intact Interaction:
PTK2
—
PXN
(colocalization, fluorescence microscopy)
Lawson et al., J Cell Biol 2012*
-
IRef Intact Interaction:
PTK2
—
PXN
(physical association, pull down)
Lawson et al., J Cell Biol 2012*
-
IRef Intact Interaction:
PTK2
—
PXN
(physical association, anti bait coimmunoprecipitation)
Tachibana et al., J Exp Med 1995*
-
IRef Intact Interaction:
PTK2
—
PXN
(physical association, pull down)
Tachibana et al., J Exp Med 1995*
-
IRef Intact Interaction:
PTK2
—
PXN
(physical association, far western blotting)
Tachibana et al., J Exp Med 1995*
-
IRef Intact Interaction:
PTK2
—
PXN
(physical association, pull down)
Fujita et al., J Biol Chem 1998*
-
IRef Intact Interaction:
PTK2
—
PXN
(physical association, anti tag coimmunoprecipitation)
Fujita et al., J Biol Chem 1998*
-
IRef Intact Interaction:
Complex of 23 proteins
(association, anti bait coimmunoprecipitation)
Thelemann et al., Mol Cell Proteomics 2005
-
IRef Intact Interaction:
Complex of 70 proteins
(association, anti bait coimmunoprecipitation)
Thelemann et al., Mol Cell Proteomics 2005
-
IRef Mppi Interaction:
PTK2
—
PXN
(coimmunoprecipitation)
Carragher et al., J Cell Biol 1999*
-
IRef Ophid Interaction:
PXN
—
PTK2
(aggregation, interologs mapping)
Brown et al., Bioinformatics 2005
-
IRef Ophid Interaction:
PTK2
—
PXN
(aggregation, confirmational text mining)
Turner et al., J Cell Biol 1999
-
IRef Ophid Interaction:
PTK2
—
PXN
(aggregation, interologs mapping)
Brown et al., Bioinformatics 2005
Text-mined interactions from Literome
Heidkamp et al., Circ Res 2002
:
Furthermore,
GFP-FRNK resulted in the loss of detectable FAK and
paxillin in focal adhesions, which was accompanied by reduced levels of total paxillin and, ultimately, cell detachment and apoptosis
Hehlgans et al., Int J Radiat Biol 2007
:
On the basis of the presented data, a precise correlation of adhesion-, serum- and
PI3K mediated changes in PI3K/AKT and
FAK/Paxillin/p130Cas signaling cascades was not found
Saito et al., Biol Pharm Bull 2008
(Wounds and Injuries) :
TNIIIA2-treatment unaffected autophosphorylation of focal adhesion kinase ( FAK ), but induced its physical association with phospho-paxillin ( Tyr118 ), suggesting the
FAK/paxillin dependent negative regulation of
Rac activation
Aponte et al., Cancer Res 2008
(Disease Progression...) :
Activation of
platelet activating factor receptor and pleiotropic
effects on tyrosine
phospho-EGFR/Src/FAK/paxillin in ovarian cancer
Tang et al., Experimental biology and medicine (Maywood, N.J.) 2009
(Carcinoma, Hepatocellular...) :
We suggest that by interaction with alpha 3beta 1 integrin,
beta ig-h3 activates
FAK-paxillin signaling linkage, leads to cytoskeleton reorganization, and thus enhances the metastatic potentials of human hepatoma cells
Koshman et al., Arterioscler Thromb Vasc Biol 2010
:
L341S-FRNK affected FA binding kinetics ( assessed by total internal reflection fluorescnece [ TIRF ] microscopy and fluorescence recovery after photobleaching [ FRAP ] ) and
reduced its steady-state
paxillin interaction ( determined by coimmunoprecipitation )
Park et al., Biochim Biophys Acta 2013
:
In conclusion, C ( 16 ) -Cer enhances mouse ESC migration through the regulation of PKC and
FAK/Paxillin dependent
N-WASP/Cdc42/Arp2/3 complex formation as well as through promoting the interaction between cofilin-1 or a-actinin-1/-4 and F-actin ... In conclusion, C ( 16 ) -Cer enhances mouse ESC migration through the regulation of PKC and
FAK/Paxillin dependent
N-WASP/Cdc42/Arp2/3 complex formation as well as through promoting the interaction between cofilin-1 or a-actinin-1/-4 and F-actin ... In conclusion, C ( 16 ) -Cer enhances mouse ESC migration through the regulation of PKC and
FAK/Paxillin dependent
N-WASP/Cdc42/Arp2/3 complex formation as well as through promoting the interaction between cofilin-1 or a-actinin-1/-4 and F-actin
Schaller et al., Mol Cell Biol 1995
:
pp125FAK dependent tyrosine phosphorylation of
paxillin creates a high-affinity binding site for Crk ... We describe here conditions under which the phosphorylation of paxillin on tyrosine is pp125FAK dependent, supporting the hypothesis that
paxillin phosphorylation is
regulated by
pp125FAK ... These observations suggest that
paxillin serves as an adapter protein, similar to insulin receptor substrate 1, and that
pp125FAK may
regulate the formation of signaling complexes by directing the phosphorylation of paxillin on tyrosine
Schaller et al., J Cell Biol 1995
:
Paxillin binding is
independent of
pp125FAK binding despite the fact that both bind to the same region of beta 1
Naruse et al., Oncogene 1998
:
Moreover, suppression of
pp125FAK expression by the antisense phosphorothioate oligodeoxynucleotides ( S-ODN ) in HUVECs
resulted in inhibition of tyrosine phosphorylation of
paxillin and the stretch dependent morphological changes